BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3359113)

  • 1. Lysophosphatidylcholine-induced arrhythmias and its accumulation in the rat perfused heart.
    Man RY
    Br J Pharmacol; 1988 Feb; 93(2):412-6. PubMed ID: 3359113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidylcholine metabolism and cardiac arrhythmias.
    Giffin M; Arthur G; Choy PC; Man RY
    Can J Physiol Pharmacol; 1988 Mar; 66(3):185-9. PubMed ID: 3383014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of reduced calcium on lysophosphatidylcholine-induced cardiac arrhythmias.
    Man RY; Lederman CL
    Pharmacology; 1985; 31(1):11-6. PubMed ID: 4023041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophosphatidylcholine accumulation in the ischemic canine heart.
    Kinnaird AA; Choy PC; Man RY
    Lipids; 1988 Jan; 23(1):32-5. PubMed ID: 3352470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidylcholine metabolism in isolated rat heart: modulation by ethanol and vitamin E.
    Choy PC; O K; Man RY; Chan AC
    Biochim Biophys Acta; 1989 Oct; 1005(3):225-32. PubMed ID: 2804051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Origin of plasma lysophosphatidylcholine: evidence for direct hepatic secretion in the rat.
    Sekas G; Patton GM; Lincoln EC; Robins SJ
    J Lab Clin Med; 1985 Feb; 105(2):190-4. PubMed ID: 3973457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new approach to the development of anti-ischemic drugs. Substances that counteract the deleterious effect of lysophosphatidylcholine on the heart.
    Hashizume H; Hoque AN; Magishi K; Hara A; Abiko Y
    Jpn Heart J; 1997 Jan; 38(1):11-25. PubMed ID: 9186278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnesium antagonizes the actions of lysophosphatidyl choline (LPC) in myocardial cells: a possible mechanism for its antiarrhythmic effects.
    Prielipp RC; Butterworth JF; Roberts PR; Black KW; Zaloga GP
    Anesth Analg; 1995 Jun; 80(6):1083-7. PubMed ID: 7762833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of endogenous and exogenous lysophosphatidylcholine in isolated perfused rat hearts.
    Sargent CA; Vesterqvist O; Ogletree ML; Grover GJ
    J Mol Cell Cardiol; 1993 Aug; 25(8):905-13. PubMed ID: 8263961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study on dilazep: II. Dilazep attenuates lysophosphatidylcholine-induced mechanical and metabolic derangements in the isolated, working rat heart.
    Hoque AN; Hoque N; Hashizume H; Abiko Y
    Jpn J Pharmacol; 1995 Mar; 67(3):233-41. PubMed ID: 7630041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphipathic lipid metabolites and their relation to arrhythmogenesis in the ischemic heart.
    DaTorre SD; Creer MH; Pogwizd SM; Corr PB
    J Mol Cell Cardiol; 1991 Feb; 23 Suppl 1():11-22. PubMed ID: 2038071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysophosphatidylcholine-induced myocardial damage is inhibited by pretreatment with poloxamer 188 in isolated rat heart.
    Watanabe M; Okada T
    Mol Cell Biochem; 2003 Jun; 248(1-2):209-15. PubMed ID: 12870676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid onset of lysophosphatidylcholine-induced modification of whole cell cardiac sodium current kinetics.
    Shander GS; Undrovinas AI; Makielski JC
    J Mol Cell Cardiol; 1996 Apr; 28(4):743-53. PubMed ID: 8732502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of verapamil on electrophysiological disturbances induced by lysophosphatidylcholine in isolated rabbit hearts.
    Nakaya H; Ozaki S; Kimura S; Gotoh Y; Kanno M
    Arch Int Pharmacodyn Ther; 1984 Jul; 270(1):88-96. PubMed ID: 6497505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of free polyunsaturated fatty acids on arrhythmias induced by lysophosphatidylcholine or palmitoylcarnitine in neonatal rat cardiac myocytes.
    Kang JX; Leaf A
    Eur J Pharmacol; 1996 Feb; 297(1-2):97-106. PubMed ID: 8851173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regulation of T-type Ca(2+) channel in lysophosphatidylcholine-stimulated cardiomyocytes].
    Liu G; Zheng MQ; Wang W; Wang XY; Ma FF; Yu HF; Li XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 43(6):804-8. PubMed ID: 22178824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidyl choline potentiates Ca2+ accumulation in rat cardiac myocytes.
    Sedlis SP; Corr PB; Sobel BE; Ahumada GG
    Am J Physiol; 1983 Jan; 244(1):H32-8. PubMed ID: 6849404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiologic effects of intracellular lysophosphoglycerides and their accumulation in cardiac lymph with myocardial ischemia in dogs.
    Akita H; Creer MH; Yamada KA; Sobel BE; Corr PB
    J Clin Invest; 1986 Jul; 78(1):271-80. PubMed ID: 3013938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitory effect of fluvastatin on lysophosphatidylcholine-induced ventricular arrhythmias in rats].
    Li LB; Wang HY; Ma L; Gao CQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Apr; 31(4):578-81. PubMed ID: 21515447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pravastatin attenuates cardiac dysfunction induced by lysophosphatidylcholine in isolated rat hearts.
    Li L; Yao Y; Wang H; Ren Y; Ma L; Yan J; Gao C
    Eur J Pharmacol; 2010 Aug; 640(1-3):139-42. PubMed ID: 20471973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.